From risk to action: Preventing health crises through NCD literacy and care 

Liver health is a growing public health priority in Europe, with chronic liver diseases and liver cancer placing increasing strain on patients, health systems, and economies.

Despite being largely preventable, liver conditions often go undetected until advanced stages, underscoring the urgent need for early detection, better care coordination, and stronger public awareness.

Through focused discussions and real-life testimonials, we will examine the challenges of managing comorbidities, the role of patient organisations in shaping care pathways, and how EU initiatives and policies can support innovative solutions, from prevention to treatment, especially in the fight against liver cancer.

Interested in this event?

Event Details

- What are the key challenges patients face in managing multiple chronic conditions?

- How can patient organisations contribute to better care coordination and more comprehensive treatment strategies for individuals with comorbidities?

- In what ways can empowering patients and strengthening patient organisations lead to meaningful improvements in healthcare systems?

Can liver cancer be prevented before it starts? These expert talks reveal how lifestyle, early detection, and smart policy can prevent liver disease and other major killers - and why prevention may be our strongest tool yet.

Can liver cancer be prevented before it starts? These expert talks reveal how lifestyle, early detection, and smart policy can prevent liver disease and other major killers - and why prevention may be our strongest tool yet.

- What urgent steps are needed to improve its early detection and treatment across Europe?

- How can integrated healthcare strategies address the link between chronic liver conditions and liver cancer within the broader non-communicable disease (NCD) framework?

- How can public health education and improved health literacy help individuals and communities take proactive steps to prevent the progression of chronic diseases?

- What important legislative actions and funds are required to support long-term health promotion and disease prevention programs at the EU level?

- How can EU policymakers improve cooperation between Member States and stakeholder engagement to ensure cohesive, inclusive, and effective public health policies?

- What role can innovation, such as data-driven care, targeted therapies, and expanded screening programmes, play in advancing public health outcomes?

Event Details
    Sponsors